Press Releases on AEFIs of COVID-19 Vaccines

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

 

Kenyataan Media Pengarah NPRA 27 April 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 22 April 2022
published on 2022-04-28


Kenyataan Media Pengarah NPRA 13 April 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 8 April 2022
published on 2022-04-14


Kenyataan Media Pengarah NPRA 6 April 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 1 April 2022
published on 2022-04-07


Kenyataan Media Pengarah NPRA 30 Mac 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 25 Mac 2022
published on 2022-03-30


Kenyataan Media Pengarah NPRA 24 Mac 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 18 Mac 2022
published on 2022-03-28


Kenyataan Media Pengarah NPRA 16 Mac 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 11 Mac 2022
published on 2022-03-18


Kenyataan Media Pengarah NPRA 9 Mac 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 4 Mac 2022
published on 2022-03-10


Kenyataan Media Bahagian Regulatori Farmasi Negara KKM - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 25 Februari 2022
published on 2022-03-04


Kenyataan Media Pengarah NPRA 23 Februari 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 18 Februari 2022
published on 2022-02-24


Kenyataan Media Pengarah NPRA 16 Februari 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 11 Februari 2022
published on 2022-02-18


National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

Image   Image   Image   Image  

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Tuesday 19 March 2024, 12:40:24.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English